Allergic Pulmonary Inflammation Through the Dectin-2 Pathway

通过 Dectin-2 途径发生的过敏性肺部炎症

基本信息

  • 批准号:
    8612049
  • 负责人:
  • 金额:
    $ 40.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-01-01 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

This application to support a new early stage investigator focuses on the role of Dectin-2 in the pathophysiology of allergen-induced pulmonary inflammation. We have previously discovered that the dendritic cell (DC) C-type lectin receptor Dectin-2 is activated by glycans found in common, clinically relevant, allergens such as the house dust mite (HDM) species Dermatophagoides farinae (Df) and Dermatophagoides pteronyssinus (Dp) and the mold Aspergillus fumigatus (Af). Activation of Dectin-2 by Df, Dp, or Af triggers production of pro-inflammatory cytokines (IL-23, IL-1 beta, IL-6, and TNF-¿) and cysteinyl leukotrienes (cys- LTs). Cys-LTs produced by such activation condition DCs in an autocrine fashion to promote Th2 immune responses, via the type 1 receptor for cysteinyl leukotrienes (cys-LTs), CysLT1R. CysLT1R signaling and Th2 priming on DCs are negatively regulated by the type 2 receptor for cys-LTs, CysLT2R. These data suggest that Th2 immunity to allergens can be finely regulated by signaling from cys-LTs. The current proposal will use mouse strains with genetic mutations in classical and novel CysLTRs to understand how they influence DC activation and Th2 priming to native allergens (Aim 1). Human monocyte-derived DCs will also be assessed by using siRNA-mediated knockdown of CysLTRs. We have identified that Dectin-2 has a critical role in triggering allergic inflammation during the challenge phase and Aim 2 of the current proposal will use in vivo models of HDM sensitization and challenge to understand the role of Dectin-2 and DCs in the elicitation phase. Greater than 50% of asthma is attributable to allergy and HDM is the most common allergen worldwide. Therefore, understanding how Dectin-2 mediates sensitization and propagation of HDM-triggered immunopathology offers a MAJOR potential therapeutic benefit.
这个应用程序支持一个新的早期阶段的调查员侧重于Dectin-2的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nora Amanda Barrett其他文献

Nora Amanda Barrett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nora Amanda Barrett', 18)}}的其他基金

Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
通过 LTE4/GPR99 相关途径引发的 2 类免疫
  • 批准号:
    10541112
  • 财政年份:
    2019
  • 资助金额:
    $ 40.55万
  • 项目类别:
Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
通过 LTE4/GPR99 相关途径引发的 2 类免疫
  • 批准号:
    10083699
  • 财政年份:
    2019
  • 资助金额:
    $ 40.55万
  • 项目类别:
Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
通过 LTE4/GPR99 相关途径引发的 2 类免疫
  • 批准号:
    10312023
  • 财政年份:
    2019
  • 资助金额:
    $ 40.55万
  • 项目类别:
Allergic Pulmonary Inflammation Through the Dectin-2 Pathway
通过 Dectin-2 途径发生的过敏性肺部炎症
  • 批准号:
    8786600
  • 财政年份:
    2014
  • 资助金额:
    $ 40.55万
  • 项目类别:
Project 2. Basal Cell Dysplasia in Type 2 Immunopathology
项目 2. 2 型免疫病理学中的基底细胞发育不良
  • 批准号:
    10456245
  • 财政年份:
    2011
  • 资助金额:
    $ 40.55万
  • 项目类别:
Project 2. Basal Cell Dysplasia in Type 2 Immunopathology
项目 2. 2 型免疫病理学中的基底细胞发育不良
  • 批准号:
    10626852
  • 财政年份:
    2011
  • 资助金额:
    $ 40.55万
  • 项目类别:
Project 2. Basal Cell Dysplasia in Type 2 Immunopathology
项目 2. 2 型免疫病理学中的基底细胞发育不良
  • 批准号:
    10260784
  • 财政年份:
    2011
  • 资助金额:
    $ 40.55万
  • 项目类别:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
先天信号传导、半胱氨酰白三烯和屋尘螨引发的哮喘
  • 批准号:
    8304953
  • 财政年份:
    2009
  • 资助金额:
    $ 40.55万
  • 项目类别:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
先天信号传导、半胱氨酰白三烯和屋尘螨引发的哮喘
  • 批准号:
    7932080
  • 财政年份:
    2009
  • 资助金额:
    $ 40.55万
  • 项目类别:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
先天信号传导、半胱氨酰白三烯和屋尘螨引发的哮喘
  • 批准号:
    8507466
  • 财政年份:
    2009
  • 资助金额:
    $ 40.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了